G Vivanet,
L Gervaso,
A Laffi, M Rubino… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Sunitinib still represents a milestone in the treatment for progressive, well-
differentiated, advanced panNETs. Areas covered We performed an evidence reappraisal to …